BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
VEGFA
,
calcium channel activity
,
Inflammatory disorder
,
Hippocampus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
histone demethylase
Summary
General Info
Curated Studies
Most Correlated Studies
Embryonic fibroblasts with knockout of histone demethylase KDM5A and re-expressing mutant KDM5A
S. cerevisiae strain W303 with knockout of histone demethylase RPH1
Breast cancer stem BCSC1 cells treated with histone demethylase KDM4 inhibitor
H3K4 histone demethylase RBP2 (retinoblastoma binding protein 2)-dependent gene expression in MEFs
Ewing sarcoma A-673 cells treated with the Jumonji-domain histone demethylase inhibitor JIB-04
Explore Curated Studies Results
Literature
Most Relevant Literature
High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethyl…
In vitro histone demethylase assay.
Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of h…
Quantitative analysis of histone demethylase probes using fluorescence polarization.
Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epit…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Assessment of [18F]MNI-1054 as a Marker for LSD1
IDH1/IDH2 Mutation Frequency in Acute Myeloblastic Patients
Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation
Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Ther…
Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatm…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ